Midterm 2 Flashcards

1
Q

Pseudomonas pathogen type

A

Opportunistic, leading cause of HAI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Who Pseudomonas affects most

A

Fibrosis patients, CFTR mutation, MDR PA with salty mucin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Pseudomonas reservoir

A

Soil, water, plants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Pseudomonas transmission

A

Healthcare workers/equipment, burn and surgery wounds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pseudomonas diseases

A

Fibrosis patients, burns and wounds, skin, eye and ear, HAI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pseudomonas binding pathogenesis

A

Pili opportunistic binding (flu expose URT/upper respiratory tract receptors), LPS bind to chloride channels in LRT/lower respiratory tract

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pseudomonas dissemination pathogenesis

A

Elastase degrades complement and elastin lung protein, ExoS ADPR G proteins to disrupt PMN, ExoA ADPR EF2 like DT, NA cleaves sialic acid, phospholipase degrades surfactants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

CF test

A

Sweat test, high sweat because salt balance is off

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pseudomonas resistance

A

Intrinsic barrier to antibiotics by forming biofilm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Special pseudomonas protocol

A

No fruits or veggies to hospital patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Pertussis past

A

One of the most frequent diseases prior to vaccination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Pertussis reservoir

A

Human aerosols

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Pertussis transmission

A

Air droplets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Pertussis diseases

A

Infants (whooping cough), Adults mild cough, Complications (secondary bacterial pneumonia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Pertussis catarrhal stage

A

Colonization first 2 weeks, very contagious, runny nose, fever, cough, bug recovered from culture, antibiotics help

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Pertussis toxemic stage

A

2-8 weeks, whooping cough, bug is gone, symptoms due to toxin PT, antibiotics don’t help

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Pertussis convalescent stage

A

Gradual recovery (months), susceptible to secondary infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Pertussis pathogenesis

A

Inhalation, attachment to ciliated cells, paralyze ciliated cells, toxins inflame RT and stop clearing of mucus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Pertussis adhesins

A

PT A1B5, and FHA (filamentous hemagglutinin) binds ciliated cells like PT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Pertussis toxins

A

PT ADPR Gi to increase cAMP (reduce phagocyte killing), introduce own ACase to increase cAMP, tracheal cytotoxin damages ciliated cells, lethal toxin necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

PT mechanism

A

Normally Gs activates ACase, all deactivated by Gi, when Gi is ADPR then the system isn’t inhibited

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Pertussis testing/detection

A

Culture 1st 2 weeks, PCR 1st 4 weeks, serology Ab test 2+ weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Pertussis prevention

A

DTaP vaccine uses PT & FHA, Tdap booster every 10 years, Tdap booster every pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Anthrax

A

Large cells with infectious spores (bioterror)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Anthrax reservoir

A

Soil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Anthrax transmission

A

Spores from animals/products (NOT human-human)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Cutaneous anthrax information

A

Most common, spores enter wound, germination, lesion develops with edema (rarely highly fatal septicemia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

GI anthrax information

A

Very rare, ingest spores from contaminated meat, invade mucosa and lymphatic system, high death rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Inhalation anthrax information

A

Infection 1wk-2mo of inhalation, germination in Macs, bacteria in bloodstream, septic shock and high death rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Anthrax capsule

A

Anti phagocytic (PGDG) poly gamma d glutamic acid resistant capsule

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Anthrax toxin

A

2A1B, protective antigen binds up to 3 A portions, lethal toxin causes lethal effects w cell lysis and cytokine storm, and edema factor causes edema in cutaneous anthrax w/ own ACase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Anthrax treatment

A

60 days, ensure all spores germinated, antibiotics good if early, antitoxin to PA (protective antigen)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Anthrax bioterror

A

Release anthrax spores into the environment or infect livestock and transmit with infected carcasses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Anthrax Pasteur vaccine

A

Inject live strain into livestock and 5 doses of IM shots with boosters for military of PA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

TB general information

A

Gram + like, acid fast +, white plague, only in humans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

TB reservoir

A

Only humans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

TB transmission

A

Highly contagious droplets/aerosols

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

LTBI information

A

Not infectious and no symptoms, skin test positive but nothing else

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

TB disease information

A

Highly infectious, skin test +, X-ray +, sputum +, cough fever, weight loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

TB predisposing factor

A

HIV knocks out CD4+ T cells, TB takes advantage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Primary TB pathogenesis

A

Inhale droplets into lung aveoli, invade Macs, body CD4+ T cell response, formation of tubercule (usually LTBI)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Primary TB disease information

A

5% of total cases, usually pulmonary, occasionally EPTB, and even more rarely military TB with cancer like tubercule formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Secondary TB information

A

5-10% of LTBI cases, tubercules break down and infectious again, rarely EPTB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

TB virulence factors

A

Resistant and waxy cell wall, has mycolic acid fatty acid chains, cord factor sticking cells together, Wax D. Also LAM (lipoarabinomannan) cell wall glycolypid which modifies phagosome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

TB diagnosis

A

Acid fast test heat/acidify bacteria (need many bugs/doesnt separate other myobacteria), NaOH sputum culture (slow generation time), PPD TST (skin test with boiled protein extract look for hard raised bump), TB blood test (most accurate, IGRA [interferon gamma release assay])

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

TB treatment

A

For LTBI INH for 9 months, for disease INH + RIF (RNA Pol Inhibitor) + EMB + PZA for 9 months, all targeting cell wall synthesis, XDR and MDR TB can form if not full course

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

TB vaccine

A

BCG live attenuated vaccine with M. bovis, scar formation administered in some countries to protect kids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Cholera general information

A

Curved rod, gram -, flagella, causes “blue death”, hella diarrhea and rapidly fatal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Cholera reservoir

A

Water/humans/shellfish

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Cholera transmission

A

Fecal/oral, NOT direct, poop water

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Cholera severity

A

10% severe, generally cleared after a week

52
Q

Cholera pathogenesis

A

Ingested and adheres to small intestine, produces cholera toxin (CT) and acts on mucosal cells causing huge diarrhea and dehydration/circulatory collapse

53
Q

Cholera symptoms

A

Typically very fast (<1 day), extreme thirst, cramps and blue skin, liquid stool and shock, rice water stool

54
Q

Cholera adherence

A

Tcp (toxin coregulated pilus) binds to small intestinal mucosa, NA, CT

55
Q

Cholera toxin

A

5B1A, ADPR Gs, binds to mucosal surfaces

56
Q

Cholera toxin mechanism

A

ADPR Gs to not allow Gi to inhibit the production of ACase, raise cAMP, phosphorylation of chloride ion channel, chloride/K+ leaves and so does water

57
Q

Cholera treatment

A

Rehydration, necessary to have glucose included for uptake

58
Q

Cholera vaccine

A

VAXCHORA live attenuated vaccine with deleted A portion, given to travelers

59
Q

C. diff general information

A

Gram +, forms spores, causes watery diarrhea and colitis, very resistant to most things other then bleach

60
Q

C. diff risk factors

A

Long term antibiotics (colon microbiome depletion)

61
Q

C. diff reservoir

A

Spores in air, soil, water, human and animal intestine

62
Q

C. diff transmission

A

Fecal-oral, spore ingestion, contaminated surfaces

63
Q

C. diff diseases

A

Pseudomembranous colitis, toxic megacolon, colon rupture

64
Q

C. diff pathogenesis

A

Ingested spores, germination and colonization of colon, produce TcdA and TcdB, diarrhea and ulceration, sepsis and death

65
Q

TcdA and TcdB mechanisms

A

Largest known toxins, UDP glycosylate G proteins, block Rho GTPase activity, different B portions recognize different epithelial cell surfaces, result in disruption of tight junctions and increase inflammatory response

66
Q

C. diff testing

A

ELISA Ab test for A and B in feces, NAAT for toxin gene in stool (PCR)

67
Q

C. diff treatment

A

Antibiotics, oral vancomycin, FMT (fecal microbiome transplant)

68
Q

C. diff prevention

A

Contact precaution (wash hands), bleach contaminated surfaces, avoid unnecessary antibiotics

69
Q

Kleb. pneumoniae information

A

Gram -, principally extracellular, carbapenem resistant

70
Q

Kleb. pneumoniae risk factors

A

Ventilators, catheters, IV, long term antibiotics

71
Q

Kleb. pneumoniae reservoir

A

human intestine and oropharynx

72
Q

Kleb. pneumoniae transmission

A

Person to person, NOT air, usually medical device/contaminated hands

73
Q

Kleb. pneumoniae diseases

A

Pneumonia, UTI, sepsis

74
Q

Kleb. pneumoniae pneumonia pathogenesis

A

Colonize oropharynx, inhalation and biofilm growth in lung, pneumonia and lung scarring, bacteremia and sepsis

75
Q

Kleb. pneumoniae virulence (HV strains)

A

Hypercapsule (77 types), pili biofilm formation, LPS block C1 binding and inflammatory response, siderophore iron scavenging proteins

76
Q

Kleb. pneumoniae diagnosis

A

Respiratory panel PCR

77
Q

Kleb. pneumoniae treatment

A

Bug is carbapenem resistant due to outer membrane alterations and efflux pump up-regulation and (ESBL) extended spectra beta lactate enzymes which break down penicillins

78
Q

Salmonella general info

A

Gram -, motile rod with flagella, food poisoning and typhoid fever, many variants

79
Q

(NTS) Non-typhoidal salmonella information

A

Largest food borne bacterial disease cause

80
Q

NTS reservoir

A

Human and animal intestinal tract

81
Q

NTS transmission

A

Contaminated food and water

82
Q

NTS disease

A

Food poisoning

83
Q

NTS symptoms

A

12-72h after infection diarrhea, cramping, fever for up to 1 week and asymptomatic carrier for up to 3 months

84
Q

NTS pathogenesis

A

Ingestion, invade enterocytes, replicate in macrophage

85
Q

NTS virulence

A

Pef (plasmid encoded fimbriae) adhesin which bind to microvilli, Salmonella pathogenicity islands (T3SS) invade cells, SPI-1 mucosal invasion and SPI-2 systemic survival produces SpvB toxin which ADPR actin to dusrupt cytoskeleton

86
Q

S. typhi special feature

A

Found only in humans

87
Q

S. typhi reservoir

A

Human intestine/gallbladder and shellfish

88
Q

S. typhi transmission

A

Poop contaminated food/water

89
Q

S. typhi symptoms

A

Sustained high fever, stuporous state, body aches, flushed appearance, diarreah

90
Q

S. typhi asymptomatic carriers

A

Around 5% of affected, carriers for months-years

91
Q

S. typhi disease

A

Typhoid fever

92
Q

Typhoid fever incubation phase

A

Ingestion, growth in macrophages in MLN (lymph nodes), 1 -3 weeks

93
Q

Typhoid fever systemic period

A

Septicemia intestinal ulcers, typhoid toxin LPS shock

94
Q

Typhoid fever asymptomatic period

A

Live in gallbladder, shed bugs for years, hard to clear with antibiotics (targeting to gallbladder)

95
Q

S. typhi virulence

A

Typhoid toxin A1B2, (hybrid of PT/CDT)
A1-PltA=pertussis-like toxin ADPR unknown target
A2-CdtB (cytolethal distending toxin)=DNAse activity
B-PltB=Binds only to human glycoprotein target

Antiphagocytic Vi (virulence) capsule

96
Q

S. typhi prevention

A

Water sanitation

97
Q

S. typhi treatment

A

Antibiotics

98
Q

S. typhi vaccine

A

Live attenuated oral for travelers, Vi capsule IM shot

99
Q

Diarrheagenic E. coli information

A

Gram -, flagellated rod
O antigen = LPS
H antigen = Flagella
K antigen = capsule
Top 6 pathogen for death because of resistance

100
Q

ETEC (enterotoxigenic E. coli)

A

Traveler’s diarrhea, human/animal reservoir, noninvasive

101
Q

ETEC virulence

A

Noninvasive, small intestine adherence, LT (heat labile toxin) ADPR Gs, ST (heat stable toxin) activates GCase, increase cGMP for water release, no inflammatory response

102
Q

EAEC (enteroaggregative E. coli)

A

Persistent watery diarrhea in children, human only reservoirs

103
Q

EAEC virulence

A

Noninvasive but clump aggregation, EAST (EA stable toxin) activates GCase like ST, hemolysin like toxin, no inflammatory response

104
Q

EPEC (enteropathogenic E. coli)

A

Watery/bloody diarrhea, human reservoir, moderately invasive

105
Q

EPEC virulence

A

EAF (EPEC adherence factor), intimin (glue) no microvilli at binding sites, pedestal under bacteria, no diarrheal toxin, disrupt signal transduction

106
Q

EHEC (enterohemorrhagic E. coli) / STEC

A

Shiga toxin producing E. coli, livestock reservoir

107
Q

EHEC virulence

A

Moderately invasive, intimin, Shiga toxin (A1B5) stops protein synthesis by cleaving 28s RNA, only human receptor

108
Q

EHEC diseases

A

HC (hemorrhagic colitis) causes bloody diarrhea and HUS (hemolytic uremic syndrome) causes kidney/organ failure with bloody urine

109
Q

EIEC (enteroinvasive E. coli)

A

Dysentery, bloody and mucous diarrhea, human reservoir

110
Q

EIEC virulence

A

Very invasive, colon adherence, spread laterally to adjacent cells, no diarrheal toxin, damage due to mucosal destruction

111
Q

Types of ExPEC (extraintestinal pathogenic E. coli)

A

UPEC (urpopathogenic E. coli), NMEC (neonatal meningitis E. coli), SEPEC (sepsis associated E.coli)

112
Q

Cause of UTIs

A

90% of the time, UPEC

113
Q

UTI/UPEC reservoir

A

Colon and vaginal colinzation

114
Q

UTI/UPEC transmission

A

From colon or vagina or sex, most common in women due to anatomy

115
Q

Community acquired UTI/UPEC pathogenesis

A

Ascending infection, urethra (urine discharge), bladder (cystitis), ureters (tubes), kidneys (pyelonephritis and sepsis)

116
Q

HAI UTI/UPEC pathogenesis

A

Ascending infection due to catheter restricting fast flow and rarely hematogenous UTI from blood infection

117
Q

UPEC adhesion

A

Pap pili (pyelonephritis associated pili) for uroepithelial cell adhesion and mountain climbing, type 1 pili bind to bladder cells and promote invasion, Tamm-Horsfall protein/uromodulin (THP) most abundant urine protein to clear type 1 pili by binding, S fimbriae (sfa) bind intestinal epithelial cells

118
Q

Other UPEC virulence

A

Hemolysin (HlyA) pore forming toxin causes damage in pyelonephritis and promotes invasion, LPS fatty acid bind O antigen core, mediates bladder colonization, resistance to hydrophobic antibiotics and toxins, siderophores, and K1 sialic acid capsule

119
Q

UPEC prevention

A

Wipe front to back, pee after sex, cranberry juice prevent type 1 pili binding

120
Q

UPEC treatment

A

Antibiotics, but disrupt normal colon/vagina flora, and spermicides inhibit lactobacillus

121
Q

NMEC disease

A

Leading cause of infant meningitis

122
Q

NMEC reservoir

A

Human GI/vagina

123
Q

NMEC transmission

A

Like GBS, prenatal due to trauma or procedure, early onset due to exposure during delivery, and late onset due to caregivers or invasive devices

124
Q

NMEC virulence

A

S fimbriae adhesion to EC components, IbeABC allows crossing of blood brain barrier, siderophores, and K1 sialic acid capsule

125
Q

NMEC treatment

A

Antibiotics (no vaccine)